Page 215 - The Vasculitides Volumes 2

Peripheral Nerve Vasculitis: Classification and Disease Associations 191

[87] Sugiura, M., Koike, H., Iijima, M., et al. Clinicopathologic features of nonsystemic
vasculitic neuropathy and microscopic polyangiitis-associated neuropathy: a
comparative study. J. Neurol. Sci. 2006; 241:31-37.

[88] Dyck, P. J. B., Norell, J. E., Dyck, P. J. Microvasculitis and ischemia in diabetic
lumbosacral radiculoplexus neuropathy. Neurology 1999; 53:2113-2121.

[89] Dyck, P. J. B., Windebank, A. J. Diabetic and nondiabetic lumbosacral radiculoplexus
neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 2002; 25:
477-491.

[90] Younger, D. S. Diabetic lumbosacral radiculoplexus neuropathy: a postmortem studied
patient and review of the literature. J. Neurol. 2011; 258:1364-1367.

[91] Massie, R., Mauermann, M. L., Staff, N. P., et al. Diabetic cervical radiculoplexus
neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus
neuropathies. Brain 2012;135:3074-3088.

[92] Garces-Sanchez, M., Laughlin, R. S., Dyck, P. J. B., et al. Painless diabetic motor
neuropathy: a variant of diabetic lumbosacral radiculoplexus Neuropathy? Ann. Neurol.
2011;69:1043-1054.

[93] Jennette, J. C., Falk, R. J., Hu, P., et al. Pathogenesis of antineutrophil cytoplasmic
autoantibody-associated small-vessel vasculitis. Annu. Rev. Pathol. 2013; 8:139-160.

[94] Savige, J., Gillis, D., Benson, E., et al. International consensus statement on testing and
reporting of antineutrophil cytoplasmic antibodies (ANCA). Am. J. Clin. Pathol. 1999;
111: 507-513.

[95] Csernok, E., Holle, J. U. Twenty-years with ANCA: how to test for ANCA-evidence
based immunology? Autoimmune Highlights 2010; 1:39-45.

[96] Csernok, E., Lamprecht, P., W. L. Gross. Diagnostic significance of ANCA in
vasculitis. Nat. Clin. Pract. Rheumatol. 2006; 2:174-175.

[97] Vital, C., Vital, A., Canron, M.-H., et al. Combined nerve and muscle biopsy in the
diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J.
Peripher. Nerv. Syst. 2006; 11:20-29.

[98] Vrancken, A. F., Gathier, C. S., Cats, E. A., et al. The additional yield of combined
nerve/muscle biopsy in vasculitic neuropathy. Eur. J. Neurol. 2011;18:49-58.

[99] Chalk, C. H., Homburger, H. A., Dyck, P. J. Anti-neutrophil cytoplasmic antibodies in
vasculitis peripheral neuropathy. Neurology 1993; 43:1826-1827.

[100] Deprez, M., de Groote, C. C., Gollogly, L., et al. Clinical and neuropathological
parameters affecting the diagnostic yield of nerve biopsy. Neuromuscul. Disord. 2000;
10:92-98.

[101] Watts, R. A., Scott, D. G., Pusey, C. D., et al. Vasculitis-aims of therapy. An overview.
Rheumatology 2000; 39:229-232.

[102] Pagnoux, C., Guillevin, L. Peripheral neuropathy in systemic vasculitides. Curr. Opin.
Rheumatol. 2005;17:41-48.

[103] Gorson, K. C. Vasculitic neuropathies: an update. Neurologist. 2007;13:12-19.
[104] Lapraik, C., Watts, R., Bacon, P., et al. BSR and BHPR guidelines for the management

of adults with ANCA associated vasculitis. Rheumatology 2007; 46:1615-1616.
[105] Mukhtyar, C., Guillevin, L., Cid, M. C., et al. EULAR recommendations for the

management of primary small and medium vessel vasculitis. Ann. Rheum. Dis. 2009;
68: 310-317.

Complimentary Contributor Copy